Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Jie Zhang · SciRah

Researcher profile · Semantic Scholar

Jie Zhang

Share profile

Jie Zhang — researcher profile on SciRah

h-index: 24
Works: 82
Citations: 1,826

Most-cited papers

Pulmonary medication adherence and health-care use in cystic fibrosis.
A. Quittner, Jie Zhang, M. Marynchenko, P. Chopra +3 more
2014Chest236 citations
Semantic Scholar
Brain metastases in patients with ALK+ non-small cell lung cancer: clinical symptoms, treatment patterns and economic burden
A. Guerin, M. Sasane, Jie Zhang, K. Culver +3 more
2015Journal of Medical Economics104 citations Open access
Semantic Scholar
A process for assessing the feasibility of a network meta-analysis: a case study of everolimus in combination with hormonal therapy versus chemotherapy for advanced breast cancer
S. Cope, Jie Zhang, S. Saletan, B. Smiechowski +2 more
2014BMC Medicine104 citations Open access
Semantic Scholar
Inhaled corticosteroid use in patients with chronic obstructive pulmonary disease and the risk of pneumonia: a retrospective claims data analysis
B. Yawn, Yunfeng Li, H. Tian, Jie Zhang +2 more
2013International Journal of COPD98 citations Open access
Semantic Scholar
Predicting Real-World Effectiveness of Cancer Therapies Using Overall Survival and Progression-Free Survival from Clinical Trials: Empirical Evidence for the ASCO Value Framework.
D. Lakdawalla, J. Shafrin, Ning-Qi Hou, D. Peneva +5 more
2017Value in Health79 citations Open access
Semantic Scholar
Variation in adherence with Global Initiative for Chronic Obstructive Lung Disease (GOLD) drug therapy guidelines: a retrospective actuarial claims data analysis
K. Fitch, K. Iwasaki, B. Pyenson, C. Plauschinat +1 more
2011Current Medical Research and Opinion76 citations
Semantic Scholar
Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trial
T. Laetsch, G. D. Myers, A. Baruchel, A. Dietz +22 more
2019The Lancet Oncology73 citations Open access
Semantic Scholar
Patient-reported long-term quality of life after tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma.
R. Maziarz, E. Waller, U. Jaeger, Isabelle Fleury +17 more
2020Blood Advances71 citations Open access
Semantic Scholar
Real-world patterns of endocrine therapy for metastatic hormone-receptor-positive (HR+)/human epidermal growth factor receptor-2-negative (HER2−) breast cancer patients in the United States: 2002–2012
E. Swallow, Jie Zhang, Darren Thomason, Ruo-Ding Tan +2 more
2014Current Medical Research and Opinion67 citations
Semantic Scholar
The Disability Burden of COPD
Julia Thornton Snider, J. Romley, Ken S. Wong, Jie Zhang +2 more
2012COPD57 citations Open access
Semantic Scholar
Nationwide trends in the medical care costs of privately insured patients with cystic fibrosis (CF), 2001–2007
Becky A. Briesacher, Alexandra L. Quittner, H. Fouayzi, Jie Zhang +1 more
2011Pediatric Pulmonology51 citations
Semantic Scholar
Impact of omalizumab on emergency-department visits, hospitalizations, and corticosteroid use among patients with uncontrolled asthma.
M. Lafeuille, J. Dean, Jie Zhang, M. Duh +2 more
2012Annals of Allergy, Asthma & Immunology47 citations
Semantic Scholar
Comparative Efficacy of Ceritinib and Crizotinib as Initial ALK–Targeted Therapies in Previously Treated Advanced NSCLC: An Adjusted Comparison with External Controls
D. S. Tan, A. Araújo, Jie Zhang, J. Signorovitch +3 more
2016Journal of Thoracic Oncology45 citations Open access
Semantic Scholar
Disease management patterns for postmenopausal women in Europe with hormone-receptor-positive, human epidermal growth factor receptor-2 negative advanced breast cancer
F. André, P. Neven, N. Marinsek, Jie Zhang +5 more
2014Current Medical Research and Opinion41 citations Open access
Semantic Scholar
A Review of Two Regulatory Approved Anti-CD19 CAR T-Cell Therapies in Diffuse Large B-Cell Lymphoma: Why Are Indirect Treatment Comparisons Not Feasible?
Jie Zhang, Jun-Long Li, Qiufei Ma, Hong-Bo Yang +2 more
2020Advances in Therapy40 citations Open access
Semantic Scholar
Integrating expert opinion with clinical trial data to extrapolate long-term survival: a case study of CAR-T therapy for children and young adults with relapsed or refractory acute lymphoblastic leukemia
S. Cope, D. Ayers, Jie Zhang, K. Batt +1 more
2019BMC Medical Research Methodology39 citations Open access
Semantic Scholar
The association of chemotherapy versus hormonal therapy and health outcomes among patients with hormone receptor-positive, HER2−negative metastatic breast cancer: experience from the patient perspective
Shaloo Gupta, Jie Zhang, G. Jerusalem
2014Expert review of pharmacoeconomics & outcomes research35 citations Open access
Semantic Scholar
Comparative efficacy of everolimus plus exemestane versus fulvestrant for hormone-receptor-positive advanced breast cancer following progression/recurrence after endocrine therapy: a network meta-analysis
T. Bachelot, R. McCool, S. Duffy, Julie May Glanville +4 more
2013Breast Cancer Research and Treatment35 citations Open access
Semantic Scholar
Survival after stem-cell transplant in pediatric and young-adult patients with relapsed and refractory B-cell acute lymphoblastic leukemia
A. Crotta, Jie Zhang, C. Keir
2018Current Medical Research and Opinion32 citations
Semantic Scholar
Outcome of Multimodality Treatment for 188 Cases of Type B3 Thymoma
Lan-Ting Gao, Chang-Lu Wang, W. Fang, Jie Zhang +2 more
2013Journal of Thoracic Oncology32 citations Open access
Semantic Scholar
Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD
Julia Thornton Snider, Y. Luna, Ken S. Wong, Jie Zhang +3 more
2012Current Medical Research and Opinion31 citations Open access
Semantic Scholar
Association between consistent omalizumab treatment and asthma control.
M. Lafeuille, J. Gravel, Jie Zhang, B. Gorsh +2 more
2013Journal of Allergy and Clinical Immunology: In Practice30 citations Open access
Semantic Scholar
Efficacy of once-daily indacaterol 75 μg relative to alternative bronchodilators in COPD: A study level and a patient level network meta-analysis
S. Cope, Jie Zhang, James D. Williams, J. Jansen
2012BMC Pulmonary Medicine25 citations Open access
Semantic Scholar
Characteristics, treatment patterns, and survival among ALK+ non-small cell lung cancer (NSCLC) patients treated with crizotinib: A chart review study.
J. Cadranel, Keunchil Park, O. Arrieta, M. Pless +10 more
2016Lung Cancer24 citations
Semantic Scholar
Health-related quality of life and disease symptoms in postmenopausal women with HR+, HER2− advanced breast cancer treated with everolimus plus exemestane versus exemestane monotherapy
M. Campone, J. Beck, M. Gnant, P. Neven +19 more
2013Current Medical Research and Opinion24 citations
Semantic Scholar
Evaluating cost benefits of combination therapies for advanced melanoma
I. Jensen, E. Zacherle, C. Blanchette, Jie Zhang +1 more
2016Drugs in Context23 citations Open access
Semantic Scholar
ALK rearrangement testing and treatment patterns for patients with ALK-positive non-small cell lung cancer.
A. Guerin, M. Sasane, Jie Zhang, A. Macalalad +6 more
2015Cancer Epidemiology23 citations
Semantic Scholar
Economic Analysis of Alternative Strategies for Detection of ALK Rearrangements in Non Small Cell Lung Cancer
Shivang Doshi, David Ray, K. Stein, Jie Zhang +5 more
2016Diagnostics22 citations Open access
Semantic Scholar
Burden of illness of patients with allergic asthma versus non-allergic asthma
M. Lafeuille, J. Gravel, M. Figliomeni, Jie Zhang +1 more
2013Journal of Asthma21 citations
Semantic Scholar
Evaluating Expected Costs and Benefits of Granting Access to New Treatments on the Basis of Progression-Free Survival in Non-Small-Cell Lung Cancer.
D. Lakdawalla, Jacquelyn W. Chou, M. Linthicum, J. MacEwan +2 more
2015JAMA Oncology20 citations
Semantic Scholar
Cost associated with hematopoietic stem cell transplantation: a retrospective claims data analysis in Germany.
L. Mayerhoff, M. Lehne, L. Hickstein, T. Salimullah +3 more
2019Journal of Comparative Effectiveness Research18 citations Open access
Semantic Scholar
Cost-effectiveness of ceritinib in patients previously treated with crizotinib in anaplastic lymphoma kinase positive (ALK+) non-small cell lung cancer in Canada
M. Hurry, Zheng-Yi Zhou, Jie Zhang, Chenxue Zhang +3 more
2016Journal of Medical Economics17 citations Open access
Semantic Scholar
Budget impact model of tobramycin inhalation solution for treatment of Pseudomonas aeruginosa in cystic fibrosis patients
T. Woodward, Ruth M. Brown, P. Sacco, Jie Zhang
2010Journal of Medical Economics16 citations Open access
Semantic Scholar
Cost of adverse events during treatment with everolimus plus exemestane or single-agent chemotherapy in patients with advanced breast cancer in Western Europe
M. Campone, Hong-Bo Yang, E. Faust, Andrew Kageleiry +3 more
2014Journal of Medical Economics14 citations Open access
Semantic Scholar
The potential impact of CAR T-cell treatment delays on society.
J. Snider, M. Brauer, Rebecca Kee, K. Batt +3 more
2019American Journal of Managed Care13 citations
Semantic Scholar
CAR-T therapy and historical trends in effectiveness and cost-effectiveness of oncology treatments.
J. Baumgardner, M. Brauer, Jie Zhang, Y. Hao +2 more
2020Journal of Comparative Effectiveness Research12 citations
Semantic Scholar
The Trade-off Between Speed and Safety in Drug Approvals.
A. Jena, Jie Zhang, D. Lakdawalla
2017JAMA Oncology10 citations
Semantic Scholar
Best Practices in LC‐MS Method Development and Validation for Dried Blood Spots
Jie Zhang, T. Majumdar, J. Flarakos, Francis L. S. Tse
20138 citations
Semantic Scholar
Efficacy of indacaterol 75 μg versus fixed-dose combinations of formoterol-budesonide or salmeterol-fluticasone for COPD: a network meta-analysis
S. Cope, M. Kraemer, Jie Zhang, G. Capkun-Niggli +1 more
2012International Journal of COPD8 citations Open access
Semantic Scholar
Lifetime Costs for Treated Follicular Lymphoma Patients in the US
C. Eichten, Qiufei Ma, T. Delea, M. Hagiwara +4 more
2021PharmacoEconomics (Auckland)7 citations
Semantic Scholar
Characteristics and outcomes of ALK+ non‐small cell lung cancer patients in Korea
Sung-Hee Lim, K. Yoh, J. S. Lee, M. Ahn +11 more
2017Asia-Pacific Journal of Clinical Oncology7 citations
Semantic Scholar
The value of surrogate endpoints for predicting real-world survival across five cancer types
J. Shafrin, R. Brookmeyer, D. Peneva, Jinhee Park +3 more
2016Current Medical Research and Opinion7 citations
Semantic Scholar
Patterns of resource utilization and cost for postmenopausal women with hormone-receptor–positive, human epidermal growth factor receptor-2–negative advanced breast cancer in Europe
G. Jerusalem, P. Neven, N. Marinsek, Jie Zhang +5 more
2015BMC Cancer7 citations Open access
Semantic Scholar
Concomitant Asthma Medication Use in Patients Receiving Omalizumab: Results from Three Large Insurance Claims Databases
M. Lafeuille, M. Duh, Jie Zhang, D. Wertz +3 more
2011Journal of Asthma7 citations
Semantic Scholar
Modeling the effects of omalizumab over 5 years among patients with moderate-to-severe persistent allergic asthma
Helene L. Grossman, A. Schlender, P. Alperin, Elizabeth L. Stanley +1 more
2010Current Medical Research and Opinion7 citations
Semantic Scholar
Tisagenlecleucel versus historical standard therapies for pediatric relapsed/refractory acute lymphoblastic leukemia.
Qiufei Ma, Jie Zhang, E. O'Brien, Amber Martin +1 more
2020Journal of Comparative Effectiveness Research6 citations Open access
Semantic Scholar
Economic Burden of Neurologic Toxicities Associated with Treatment of Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma in the United States.
M. Broder, Qiufei Ma, T. Yan, Jie Zhang +3 more
2020American health & drug benefits5 citations
Semantic Scholar
Letter to Editor Regarding "Comparing Efficacy, Safety, and Pre-Infusion Period of Axicabtagene Ciloleucel vs Tisagenlecleucel in Relapsed/Refractory Large B-Cell Lymphoma".
Jie Zhang, Jun-Long Li, Qiufei Ma, Hong-Bo Yang +2 more
2020Biology of Blood and Marrow Transplantation5 citations Open access
Semantic Scholar
Is time to progression associated with post-progression survival in previously treated metastatic non-small cell lung cancer with BRAF V600E mutation? A secondary analysis of phase II clinical trial data
Jun-Long Li, M. Sasane, Jie Zhang, Jing Zhao +4 more
2018BMJ Open5 citations Open access
Semantic Scholar
The Economic Value of CTL019 Therapy for Pediatric Patients with Relapsed and Refractory Acute Lymphoblastic Leukemia in the United Kingdom
J. Snider, M. Brauer, Y. Hao, P. Karaca-Mandic +3 more
20175 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Signorovitch×7
Invite
J. Signorovitch — researcher profile on SciRah
Qiufei Ma×6
Invite
Qiufei Ma — researcher profile on SciRah
D. Lakdawalla×5
Invite
D. Lakdawalla — researcher profile on SciRah
Andrew Kageleiry×5
Invite
Andrew Kageleiry — researcher profile on SciRah

×4

Invite

M. Sasane — researcher profile on SciRah

Invite

E. Wu — researcher profile on SciRah

Invite

S. Cope — researcher profile on SciRah

Invite

J. Jansen — researcher profile on SciRah

Invite

D. Goldman — researcher profile on SciRah

M. Lafeuille×4

Invite

M. Lafeuille — researcher profile on SciRah

Invite

P. Lefebvre — researcher profile on SciRah

Invite

R. Degun — researcher profile on SciRah